Please login to the form below

Not currently logged in
Email:
Password:

Richard Vellacott joins Horizon Discovery as chief financial officer

His 15 years’ industry includes time in Deloitte’s life sciences practice

Cambridge, UK-based personalised medicine research tool firm Horizon Discovery has appointed Richard Vellacott as chief financial officer.

He was most recently vice president, finance at hi-tech company CSR, but joins Horizon with over 15 years' experience in working with life science companies.

During this time Vellacott served as a director in Deloitte's life sciences practice, where he specialised in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets.

Horizon's CEO Dr Darrin Disley said: “I'm delighted to welcome Richard to Horizon. As the company continues to expand, it is essential that we maintain a highly experienced executive team with the skills to deliver our growth objectives. Richard's background is an ideal fit and I very much look forward to working with him.”

8th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....
Pharma China Annual Forum 2017
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China....

Infographics